Breaking: Scientists Find Molecule That Successfully Slows Aging
Russian & Swedish Biologists have tested the SKQ1 molecule and found that it successfully slows cellular aging in mice. This is an anti-aging breakthrough.
The main aim of this study was to investigate the role of our mitochondria (the power house of the cell) in aging. Researchers have found that the SKQ1 molecule, discovered several years ago, works in the mitochondria as an effective anti-aging treatment. This research is as a result of the combined efforts of Moscow State University and Stockholm university.
The Breakthrough Anti-Aging Study
The scientists conducted the study by separating a group of mice into two. The first group received normal food, while the second was fed food containing the SKQ1 molecule. This molecule is a powerful antioxidant.
When the mice reached eight months of age, the difference between the two groups became clear. The first group started to lose weight and hair as well as experience spinal deformation. They also showed other signs of aging such as a decrease in temperature and thinner skin. The second group showed no signs of aging until 40-45 days later. These result have been published in the journal Aging and show a 15% reduction in aging.
How Important Is This Study?
Vladimir Skulachev Academician is the Dean of the Faculty of Bioinformatics at the Moscow State University told Sputnik. He says, “This work is relevant both from theoretical and practical point of view. On the one hand, it has demonstrated the key role that reactive oxygen species produced by mitochondria play in the aging of a mammalian organism. On the other hand, we have found new opportunities for the aging treatment with antioxidants, specifically targeting the mitochondria.”
Skulachev describes himself as a supporter of the theory of August Weismann. Weismann’s theory say that death and aging are not random processes of the decay of body tissues and cells, but a purposeful evolutionary process. Which force the old organisms to give way to new generations of living beings.
Based on this idea, Skulachev and his scientific team had been working on creating drugs that can decelerate the process of aging in our mitochondria – one of the most important parts of our cells.
When Will This Be Available On The Market?
Skulachev’s project is now developing a set of pharmaceuticals based on SkQ1 molecule, according to Eureka Alert.
The first drug – Visomitin eye drops – is already approved and marketed in Russia. It also passed phase 2 clinical trials in the U.S.
The next pharmaceutical product in project’s pipeline is an oral form of SkQ1 (similar to the one used in the experiment). It is now in the process of clinical trials in Russia. In case of positive results of these trials, an anti-aging medication could be approved for systemic indications in 2-3 years.
Did you enjoy this post? Read Why 7 Nobel Prize Winners Do Not Validate This Anti-Aging Supplement.